{"DataElement":{"publicId":"2626075","version":"1","preferredName":"Cancer and Leukemia Group B Patient Inclusion Clinical Trial Eligibility Criteria 40503 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"C_PT_IN_CTE_40503_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2625931","version":"1","preferredName":"Cancer and Leukemia Group B Patient Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"CALGB_PT_INCL_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2625929","version":"1","preferredName":"Cancer and Leukemia Group B Patient","preferredDefinition":"The Cancer and Leukemia Group B (CALGB) is a national clinical research group - network of 29 university medical centers, over 185 community hospitals and more than almost 3000 physicians - sponsored by the NCI, with its Central Office headquartered at the University of Chicago, and its Statistical Center located at Duke University, founded in 1955 with a goal of bringing together clinical and laboratory research.:A person who requires medical care.","longName":"C25442:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer and Leukemia Group B","conceptCode":"C25442","definition":"A national clinical research group - network of 29 university medical centers, over 185 community hospitals and more than almost 3000 physicians - sponsored by the NCI, with its Central Office headquartered at the University of Chicago, and its Statistical Center located at Duke University, founded in 1955 with a goal of bringing together clinical and laboratory research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB1F788-C668-1ADE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"ONEDATA","dateModified":"2007-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518229","version":"1","preferredName":"Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"The addition of somebody or something to, or the presence of somebody or something in, a group or mixture, particularly, a passive, usually temporary, product of cell activity within the cytoplasm or nucleus.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25532:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Criteria","conceptCode":"C25532","definition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08D4-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB30129-B326-1BB8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2625932","version":"1","preferredName":"40503 Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility inclusion criteria for a Cancer and Leukemia Group B protocol.","longName":"40503_INCL_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Histologic dx of primary, metastatic Stage IV or locally advanced, unresectable Stage IIIB cancer of the female breast (using AJCC criteria, 6th edition) not amenable to local therapy","valueDescription":"Histologic dx of primary, metastatic Stage IV or locally advanced, unresectable Stage IIIB cancer of the female breast (using AJCC criteria, 6th edition) not amenable to local therapy","ValueMeaning":{"publicId":"2625933","version":"1","preferredName":"Histologic dx of primary, metastatic Stage IV or locally advanced, unresectable Stage IIIB cancer of the female breast (using AJCC criteria, 6th edition) not amenable to local therapy","longName":"2625933","preferredDefinition":"Histologic dx of primary, metastatic Stage IV or locally advanced, unresectable Stage IIIB cancer of the female breast (using AJCC criteria, 6th edition) not amenable to local therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB31792-7DF9-1E7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DB3217A-9090-1ECD-E044-0003BA3F9857","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"ONEDATA","dateModified":"2007-04-09","deletedIndicator":"No"},{"value":"No concurrent active secondary malignancy","valueDescription":"No concurrent active secondary malignancy","ValueMeaning":{"publicId":"2625934","version":"1","preferredName":"No concurrent active secondary malignancy","longName":"2625934","preferredDefinition":"No concurrent active secondary malignancy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB31A95-8159-1AE8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DB3217A-90A2-1ECD-E044-0003BA3F9857","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"ONEDATA","dateModified":"2007-04-09","deletedIndicator":"No"},{"value":"Tumors that are ER and/or PgR positive","valueDescription":"Tumors that are ER and/or PgR positive","ValueMeaning":{"publicId":"2625935","version":"1","preferredName":"Tumors that are ER and/or PgR positive","longName":"2625935","preferredDefinition":"Tumors that are ER and/or PgR positive","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB31498-D2AC-1BFD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DB3217A-90B4-1ECD-E044-0003BA3F9857","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"ONEDATA","dateModified":"2007-04-09","deletedIndicator":"No"},{"value":">= 18 years of age","valueDescription":">= 18 years of age","ValueMeaning":{"publicId":"2625936","version":"1","preferredName":">= 18 years of age","longName":"2625936","preferredDefinition":">= 18 years of age","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB3082C-52A5-1CB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DB3217A-90C6-1ECD-E044-0003BA3F9857","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"ONEDATA","dateModified":"2007-04-09","deletedIndicator":"No"},{"value":"ECOG (Zubrod) PS <= 1; life expectancy >=12 wk","valueDescription":"ECOG (Zubrod) PS <= 1; life expectancy >=12 wk","ValueMeaning":{"publicId":"2625937","version":"1","preferredName":"ECOG (Zubrod) PS <= 1; life expectancy >=12 wk","longName":"2625937","preferredDefinition":"ECOG (Zubrod) PS <= 1; life expectancy >=12 wk","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB32065-0BF3-1CC6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DB3217A-90D8-1ECD-E044-0003BA3F9857","beginDate":"2007-04-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"ONEDATA","dateModified":"2007-04-09","deletedIndicator":"No"},{"value":"Women can be either pre- or postmenopausal","valueDescription":"Women can be either pre- or postmenopausal","ValueMeaning":{"publicId":"2626046","version":"1","preferredName":"Women can be either pre- or postmenopausal","longName":"2626046","preferredDefinition":"Women can be either pre- or postmenopausal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC3759E-EE14-0635-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC283BF-D3C6-05A5-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Ovarian suppression required for premenopausal women","valueDescription":"Ovarian suppression required for premenopausal women","ValueMeaning":{"publicId":"2626047","version":"1","preferredName":"Ovarian suppression required for premenopausal women","longName":"2626047","preferredDefinition":"Ovarian suppression required for premenopausal women","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC3775F-A5DA-05A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC283BF-D3D8-05A5-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No prior bevacizumab or anti-VEGF therapy","valueDescription":"No prior bevacizumab or anti-VEGF therapy","ValueMeaning":{"publicId":"2626050","version":"1","preferredName":"No prior bevacizumab or anti-VEGF therapy","longName":"2626050","preferredDefinition":"No prior bevacizumab or anti-VEGF therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC3775F-A5EA-05A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC283BF-D3FC-05A5-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":">= 2 weeks since prior radiotherapy and all toxicities resolved","valueDescription":">= 2 weeks since prior radiotherapy and all toxicities resolved","ValueMeaning":{"publicId":"2626051","version":"1","preferredName":">= 2 weeks since prior radiotherapy and all toxicities resolved","longName":"2626051","preferredDefinition":">= 2 weeks since prior radiotherapy and all toxicities resolved","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC282C5-B15D-078B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC283BF-D40E-05A5-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Prior adjuvant or neoadjuvant chemotherapy allowed","valueDescription":"Prior adjuvant or neoadjuvant chemotherapy allowed","ValueMeaning":{"publicId":"2626052","version":"1","preferredName":"Prior adjuvant or neoadjuvant chemotherapy allowed","longName":"2626052","preferredDefinition":"Prior adjuvant or neoadjuvant chemotherapy allowed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC37B58-70A0-05FA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC290DD-DCA4-05B2-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No prior chemotherapy for metastatic disease","valueDescription":"No prior chemotherapy for metastatic disease","ValueMeaning":{"publicId":"2626053","version":"1","preferredName":"No prior chemotherapy for metastatic disease","longName":"2626053","preferredDefinition":"No prior chemotherapy for metastatic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC288AE-3665-0686-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC290DD-DCB6-05B2-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Bisphosphonate therapy allowed","valueDescription":"Bisphosphonate therapy allowed","ValueMeaning":{"publicId":"2626054","version":"1","preferredName":"Bisphosphonate therapy allowed","longName":"2626054","preferredDefinition":"Bisphosphonate therapy allowed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC28A6A-05DC-70DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC290DD-DCC8-05B2-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No major surgery within 28 days of registration","valueDescription":"No major surgery within 28 days of registration","ValueMeaning":{"publicId":"2626055","version":"1","preferredName":"No major surgery within 28 days of registration","longName":"2626055","preferredDefinition":"No major surgery within 28 days of registration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC28E22-FB18-05AD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC290DD-DCDA-05B2-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No history of abdominal fistula or intraabdominal abscess within 6 months nor GI perforation within 12 months of registration","valueDescription":"No history of abdominal fistula or intraabdominal abscess within 6 months nor GI perforation within 12 months of registration","ValueMeaning":{"publicId":"2626056","version":"1","preferredName":"No history of abdominal fistula or intraabdominal abscess within 6 months nor GI perforation within 12 months of registration","longName":"2626056","preferredDefinition":"No history of abdominal fistula or intraabdominal abscess within 6 months nor GI perforation within 12 months of registration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC283BF-D419-05A5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC290DD-DCEC-05B2-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No history of significant bleeding within 6 months of registration","valueDescription":"No history of significant bleeding within 6 months of registration","ValueMeaning":{"publicId":"2626057","version":"1","preferredName":"No history of significant bleeding within 6 months of registration","longName":"2626057","preferredDefinition":"No history of significant bleeding within 6 months of registration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC293E9-9595-0639-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC296FE-3E4E-05F8-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No clinically significant cardiovascular disease","valueDescription":"No clinically significant cardiovascular disease","ValueMeaning":{"publicId":"2626058","version":"1","preferredName":"No clinically significant cardiovascular disease","longName":"2626058","preferredDefinition":"No clinically significant cardiovascular disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC293E9-95A5-0639-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC296FE-3E60-05F8-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Patients on full dose anticoagulant must be on a stable dose of warfarin","valueDescription":"Patients on full dose anticoagulant must be on a stable dose of warfarin","ValueMeaning":{"publicId":"2626059","version":"1","preferredName":"Patients on full dose anticoagulant must be on a stable dose of warfarin","longName":"2626059","preferredDefinition":"Patients on full dose anticoagulant must be on a stable dose of warfarin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC296FE-3E37-05F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC296FE-3E72-05F8-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No arterial thrombotic events, TIA, CVA, acute MI or unstable angina within 6 months of registration","valueDescription":"No arterial thrombotic events, TIA, CVA, acute MI or unstable angina within 6 months of registration","ValueMeaning":{"publicId":"2626060","version":"1","preferredName":"No arterial thrombotic events, TIA, CVA, acute MI or unstable angina within 6 months of registration","longName":"2626060","preferredDefinition":"No arterial thrombotic events, TIA, CVA, acute MI or unstable angina within 6 months of registration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC298C3-4AB1-05B0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC296FE-3E84-05F8-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No known CNS metastases","valueDescription":"No known CNS metastases","ValueMeaning":{"publicId":"2626061","version":"1","preferredName":"No known CNS metastases","longName":"2626061","preferredDefinition":"No known CNS metastases","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC29A9E-218C-0963-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC296FE-3E96-05F8-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No known allergies to aromatase inhibitors or estrogen receptor modulators","valueDescription":"No known allergies to aromatase inhibitors or estrogen receptor modulators","ValueMeaning":{"publicId":"2626062","version":"1","preferredName":"No known allergies to aromatase inhibitors or estrogen receptor modulators","longName":"2626062","preferredDefinition":"No known allergies to aromatase inhibitors or estrogen receptor modulators","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC29CA7-0F26-05FC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0F4D-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"No serious, non-healing wound, ulcer or bone fx","valueDescription":"No serious, non-healing wound, ulcer or bone fx","ValueMeaning":{"publicId":"2626066","version":"1","preferredName":"No serious, non-healing wound, ulcer or bone fx","longName":"2626066","preferredDefinition":"No serious, non-healing wound, ulcer or bone fx","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC29E53-73EB-0961-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0F5F-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Granulocytes >= 1000/ul","valueDescription":"Granulocytes >= 1000/ul","ValueMeaning":{"publicId":"2626067","version":"1","preferredName":"Granulocytes >= 1000/ul","longName":"2626067","preferredDefinition":"Granulocytes >= 1000/ul","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC2808D-D3C2-0662-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0F71-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Platelet count >= 100,000/ul","valueDescription":"Platelet count >= 100,000/ul","ValueMeaning":{"publicId":"2626068","version":"1","preferredName":"Platelet count >= 100,000/ul","longName":"2626068","preferredDefinition":"Platelet count >= 100,000/ul","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC29CA7-0F36-05FC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0F83-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Creatinine <= 2.0 mg/dl","valueDescription":"Creatinine <= 2.0 mg/dl","ValueMeaning":{"publicId":"2626069","version":"1","preferredName":"Creatinine <= 2.0 mg/dl","longName":"2626069","preferredDefinition":"Creatinine <= 2.0 mg/dl","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC283BF-D429-05A5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0F95-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Bilirubin <= 1.5 x ULN unless due to Gilbert's Syndrome","valueDescription":"Bilirubin <= 1.5 x ULN unless due to Gilbert's Syndrome","ValueMeaning":{"publicId":"2626070","version":"1","preferredName":"Bilirubin <= 1.5 x ULN unless due to Gilbert's Syndrome","longName":"2626070","preferredDefinition":"Bilirubin <= 1.5 x ULN unless due to Gilbert's Syndrome","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC37927-6694-042B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0FA7-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Transaminases (ALT, AST) <= 2.5 x ULN","valueDescription":"Transaminases (ALT, AST) <= 2.5 x ULN","ValueMeaning":{"publicId":"2626071","version":"1","preferredName":"Transaminases (ALT, AST) <= 2.5 x ULN","longName":"2626071","preferredDefinition":"Transaminases (ALT, AST) <= 2.5 x ULN","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC2A94F-4A21-0673-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0FB9-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"INR <= 1.6, unless on full dose warfarin","valueDescription":"INR <= 1.6, unless on full dose warfarin","ValueMeaning":{"publicId":"2626072","version":"1","preferredName":"INR <= 1.6, unless on full dose warfarin","longName":"2626072","preferredDefinition":"INR <= 1.6, unless on full dose warfarin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC296FE-3EA1-05F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0FCB-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Beta-Hcg negative (in premenopausal women)","valueDescription":"Beta-Hcg negative (in premenopausal women)","ValueMeaning":{"publicId":"2626074","version":"1","preferredName":"Beta-Hcg negative (in premenopausal women)","longName":"2626074","preferredDefinition":"Beta-Hcg negative (in premenopausal women)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC2B195-16D7-0602-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2DC29CA7-0FEF-05FC-E044-0003BA3F9857","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"ONEDATA","dateModified":"2007-04-10","deletedIndicator":"No"},{"value":"Measurable/non-measurable disease by RECIST criteria","valueDescription":"Measurable/non-measurable disease by RECIST criteria","ValueMeaning":{"publicId":"2636459","version":"1","preferredName":"Measurable/non-measurable disease by RECIST criteria","longName":"2636459","preferredDefinition":"Measurable/non-measurable disease by RECIST criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FE29482-2A08-31B3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FE40139-EEE6-3FD3-E044-0003BA3F9857","beginDate":"2007-05-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-07","modifiedBy":"ONEDATA","dateModified":"2007-05-07","deletedIndicator":"No"},{"value":"Prior endocrine therapy not required, but is permitted in adjuvant setting; No prior endocrine therapy for metastatic disease unless initiated within 4 weeks prior to protocol registration","valueDescription":"Prior endocrine therapy not required, but is permitted in adjuvant setting; No prior endocrine therapy for metastatic disease unless initiated within 4 weeks prior to protocol registration","ValueMeaning":{"publicId":"2636460","version":"1","preferredName":"Prior endocrine therapy not required, but is permitted in adjuvant setting; No prior endocrine therapy for metastatic disease unless initiated within 4 weeks prior to protocol registration","longName":"2636460","preferredDefinition":"Prior endocrine therapy not required, but is permitted in adjuvant setting; No prior endocrine therapy for metastatic disease unless initiated within 4 weeks prior to protocol registration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FE2B9EA-B210-2E4D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FE40139-EEF8-3FD3-E044-0003BA3F9857","beginDate":"2007-05-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-07","modifiedBy":"ONEDATA","dateModified":"2007-05-07","deletedIndicator":"No"},{"value":"Urinalysis <= 1+ protein","valueDescription":"Urinalysis <= 1+ protein","ValueMeaning":{"publicId":"2674838","version":"1","preferredName":"Urinalysis <= 1+ protein","longName":"2674838","preferredDefinition":"Urinalysis <= 1+ protein","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"389BF017-A5CE-6679-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-08-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"389BF2D9-A438-6675-E044-0003BA3F9857","beginDate":"2007-08-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-08-26","modifiedBy":"ONEDATA","dateModified":"2007-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB3082C-522D-1CB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-09","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Eligibility criteria","type":"Preferred Question Text","description":"Eligibility criteria","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DC41C6F-AF40-169C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-04-10","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}